Effect of early interferon beta-1a therapy on conversion to multiple sclerosis in Iranian patients with a first demyelinating event.

Date
2007-JunAuthor
H Pakdaman
M A Sahraian
A Fallah
R Pakdaman
K Ghareghozli
M Ghafarpour
E Rahimian
A Shirani
Metadata
Show full item recordAbstract
A new treatment approach to multiple sclerosis (MS) is the initiation of interferon therapy in the early phase of the disease when a patient presents with clinically isolated syndrome.